Page 4 - Nasdaq Amph News Today

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) had its price target boosted by Piper Sandler from $43.00 to $55.00 in a research report sent to investors on Thursday, The Fly reports. Separately, StockNews.com lowered Amphastar Pharmaceuticals from a strong-buy rating to a buy rating in a research note on Tuesday, June 13th. Amphastar Pharmaceuticals Trading Up […]

Shaker Investments LLC OH raised its position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 1.1% in the fourth quarter, HoldingsChannel reports. The fund owned 81,287 shares of the company’s stock after purchasing an additional 888 shares during the quarter. Amphastar Pharmaceuticals makes up approximately 1.4% of Shaker Investments LLC OH’s holdings, making the […]

StockNews.com assumed coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a research note released on Thursday. The firm issued a strong-buy rating on the stock. Amphastar Pharmaceuticals Stock Up 0.7 % AMPH stock opened at $44.16 on Thursday. Amphastar Pharmaceuticals has a fifty-two week low of $26.76 and a fifty-two week high […]

StockNews.com initiated coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a report released on Thursday morning. The firm issued a strong-buy rating on the stock. Amphastar Pharmaceuticals Trading Up 0.7 % Shares of AMPH opened at $44.16 on Thursday. The firm has a 50 day moving average price of $39.16 and a […]

Research analysts at StockNews.com started coverage on shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “strong-buy” rating on the stock. Amphastar Pharmaceuticals Price Performance Shares of AMPH opened at $44.16 on Thursday. The company has a market capitalization of $2.13 […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, May 15th. The shares were sold at an average price of $42.18, for a total transaction of $316,350.00. Following the completion of the transaction, the director now directly owns 43,869 shares of […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Richard K. Prins sold 5,000 shares of the stock in a transaction on Friday, May 12th. The stock was sold at an average price of $42.06, for a total value of $210,300.00. Following the sale, the director now owns 47,342 shares in the company, valued at approximately […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $44.78 and last traded at $44.57, with a volume of 178928 shares changing hands. The stock had previously closed at $42.97. Wall Street Analyst Weigh In Separately, StockNews.com assumed […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Michael A. Zasloff sold 7,500 shares of the firm’s stock in a transaction on Monday, May 15th. The stock was sold at an average price of $42.18, for a total value of $316,350.00. Following the transaction, the director now owns 43,869 shares in the company, valued at […]

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) Director Richard K. Prins sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $42.06, for a total transaction of $210,300.00. Following the completion of the transaction, the director now directly owns 47,342 […]